Geacintov N E
Carcinogenesis. 1986 May;7(5):759-66. doi: 10.1093/carcin/7.5.759.
The tumorigenic and mutagenic effects induced by polycyclic aromatic diol epoxides are widely believed to involve the covalent binding of these electrophilic metabolites of polycyclic aromatic hydrocarbons to DNA. Here the relationships between the formation of non-covalent intercalation complexes with DNA, the DNA-catalyzed reaction rates, the formation of tetraols (which constitutes a detoxification pathway) and the level of covalent binding to DNA, are examined critically within the context of available experimental results. When the rates of reaction of the diol epoxide molecules at DNA binding sites dominate over those in the external aqueous solution, the level of covalent binding is independent of the intercalative non-covalent binding (association constant K, M-1) which precedes the covalent binding reaction. However, under conditions in which DNA does not catalyze or enhance the reaction rate of diol epoxide molecules (e.g. at high salt concentrations), or when there are efficient competitive reaction pathways in the solution external to the DNA, the level of covalent binding to DNA is predicted to be directly proportional to K. Since these latter reaction conditions are expected to prevail in a cellular environment, the ability of a given diol epoxide derivative to form intercalative non-covalent complexes with DNA prior to covalent binding should be an important factor in determining the biological activities of these compounds. The experimental conditions which are suitable for testing the relationships between non-covalent intercalative complex formation and covalent binding to DNA in vitro are described.
多环芳烃二醇环氧化物诱导的致瘤和诱变作用被广泛认为涉及这些多环芳烃的亲电代谢产物与DNA的共价结合。在此,结合现有实验结果,对与DNA形成非共价嵌入复合物、DNA催化的反应速率、四醇的形成(构成一种解毒途径)以及与DNA共价结合水平之间的关系进行了严格研究。当二醇环氧化物分子在DNA结合位点的反应速率超过其在外部水溶液中的反应速率时,共价结合水平与共价结合反应之前的嵌入非共价结合(缔合常数K,M⁻¹)无关。然而,在DNA不催化或不提高二醇环氧化物分子反应速率的条件下(例如在高盐浓度下),或者当DNA外部溶液中存在有效的竞争反应途径时,预计与DNA的共价结合水平与K成正比。由于预计这些后一种反应条件在细胞环境中普遍存在,给定的二醇环氧化物衍生物在共价结合之前与DNA形成嵌入非共价复合物的能力应该是决定这些化合物生物活性的一个重要因素。本文描述了适合在体外测试非共价嵌入复合物形成与DNA共价结合之间关系的实验条件。